This corresponds with ACSL3’s established role in catalysing MUFA to produce protective membrane phospholipids and, for the first time, distinctly delineates ACSL3’s inhibitory effect on ferroptosis in HCC. This evidence concerns the gene ACSL3 and hepatocellular carcinoma.